Goldman Sachs’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-41,000
Closed -$868K 6368
2024
Q4
$868K Buy
41,000
+19,000
+86% +$499K ﹤0.01% 4911
2024
Q3
$709K Buy
+22,000
New +$650K ﹤0.01% 4857

Other funds holding SGRY

Goldman Sachs's SGRY Position: Q1 2026 in Review

Goldman Sachs reduced its Surgery Partners (SGRY) stake by 35% in Q1 2026, selling an estimated $9.75M and leaving 1,280,552 shares worth $15.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2707.

Goldman Sachs first reported a position in SGRY in Q4 2015 and has held it in 37 quarters since. The position peaked at $43M in Q2 2023. 182 funds tracked by Wall St. Rank hold SGRY as of Q1 2026.

  • Goldman Sachs held 1,280,552 shares of Surgery Partners worth $15.3M as of Q1 2026.
  • Goldman Sachs sold 679,134 Surgery Partners shares in Q1 2026, an estimated $9.75M.
  • Surgery Partners made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #2707 holding.
  • Goldman Sachs first reported a position in Surgery Partners in Q4 2015 and has held it in 37 quarters since.
  • Goldman Sachs's Surgery Partners position peaked at $43M in Q2 2023.
  • 182 funds tracked by Wall St. Rank held Surgery Partners as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.